Uterine rupture with the use of Cervagem (prostaglandin E1) for induction of labour on account of intrauterine death.
Thavarasah
A S
AS
Achanna
K S
KS
D000019:Abortifacient Agents / Q000009:adverse effects*; D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000328:Adult; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005313:Fetal Death; D006801:Humans; D007751:Labor, Induced; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000009:adverse effects*; D014597:Uterine Rupture / Q000139:chemically induced*
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011459:Prostaglandins E, Synthetic; C021182:gemeprost; D000527:Alprostadil